估计原发性甲状旁腺功能亢进骨质减少患者的骨折风险。

IF 2.9 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM
Elena Castellano, Anna Garelli, Roberto Attanasio, Alberto Boriano, Giorgio Borretta
{"title":"估计原发性甲状旁腺功能亢进骨质减少患者的骨折风险。","authors":"Elena Castellano, Anna Garelli, Roberto Attanasio, Alberto Boriano, Giorgio Borretta","doi":"10.1007/s12020-025-04406-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>While osteoporosis in primary hyperparathyroidism (PHPT) is widely studied, PHPT patients with osteopenia remain less characterized. This study aimed to evaluate the prevalence, biochemical features, and estimated fracture risk of osteopenic PHPT patients in a real-life cohort.</p><p><strong>Methods: </strong>We retrospectively analyzed a consecutive series of PHPT patients with available densitometric data at three sites. Postmenopausal women and men over 50 years old with PHPT and osteopenia were selected. FRAX scores were used to estimate fracture risk, and subgroup analyses were conducted based on sex, age, and PHPT clinical presentation.</p><p><strong>Results: </strong>One hundred out of 439 PHPT patients (22.8%) were osteopenic. As compared to osteopenic women, osteopenic men were older (p = 0.03), had higher BMD at the spine and femoral neck (p = 0.007 and p = 0.006, respectively), and more frequent occurrence of nephrolithiasis (p = 0.046). Osteopenic patients older than 65 years had worst FRAX scores and higher prevalence of comorbidities, as type 2 diabetes and hypertension, than their younger counterparts (both p < 0.001). FRAX scores of osteopenic PHPT patients were not different according to their clinical classification of PHPT.</p><p><strong>Conclusions: </strong>Patients with osteopenia account for about one fifth of our whole series and two thirds of them met surgical indication according to latest international guidelines. Neither densitometric data nor estimated fracture risk differed between osteopenic PHPT patients meeting or not surgical criteria.</p>","PeriodicalId":49211,"journal":{"name":"Endocrine","volume":" ","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2025-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Estimated fracture risk in osteopenic patients with primary hyperparathyroidism.\",\"authors\":\"Elena Castellano, Anna Garelli, Roberto Attanasio, Alberto Boriano, Giorgio Borretta\",\"doi\":\"10.1007/s12020-025-04406-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>While osteoporosis in primary hyperparathyroidism (PHPT) is widely studied, PHPT patients with osteopenia remain less characterized. This study aimed to evaluate the prevalence, biochemical features, and estimated fracture risk of osteopenic PHPT patients in a real-life cohort.</p><p><strong>Methods: </strong>We retrospectively analyzed a consecutive series of PHPT patients with available densitometric data at three sites. Postmenopausal women and men over 50 years old with PHPT and osteopenia were selected. FRAX scores were used to estimate fracture risk, and subgroup analyses were conducted based on sex, age, and PHPT clinical presentation.</p><p><strong>Results: </strong>One hundred out of 439 PHPT patients (22.8%) were osteopenic. As compared to osteopenic women, osteopenic men were older (p = 0.03), had higher BMD at the spine and femoral neck (p = 0.007 and p = 0.006, respectively), and more frequent occurrence of nephrolithiasis (p = 0.046). Osteopenic patients older than 65 years had worst FRAX scores and higher prevalence of comorbidities, as type 2 diabetes and hypertension, than their younger counterparts (both p < 0.001). FRAX scores of osteopenic PHPT patients were not different according to their clinical classification of PHPT.</p><p><strong>Conclusions: </strong>Patients with osteopenia account for about one fifth of our whole series and two thirds of them met surgical indication according to latest international guidelines. Neither densitometric data nor estimated fracture risk differed between osteopenic PHPT patients meeting or not surgical criteria.</p>\",\"PeriodicalId\":49211,\"journal\":{\"name\":\"Endocrine\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2025-09-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Endocrine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s12020-025-04406-5\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12020-025-04406-5","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

背景:虽然原发性甲状旁腺功能亢进症(PHPT)的骨质疏松症被广泛研究,但PHPT患者骨质减少的特征仍然较少。本研究旨在评估现实生活中骨质减少的PHPT患者的患病率、生化特征和估计的骨折风险。方法:我们回顾性分析了一系列连续的PHPT患者的三个部位的可用密度测量数据。绝经后女性和50岁以上伴有PHPT和骨质减少的男性被选中。FRAX评分用于评估骨折风险,并根据性别、年龄和PHPT临床表现进行亚组分析。结果:439例PHPT患者中有100例(22.8%)骨质减少。与骨质减少的女性相比,骨质减少的男性年龄更大(p = 0.03),脊柱和股骨颈的骨密度更高(p = 0.007和p = 0.006),肾结石的发生率更高(p = 0.046)。65岁以上的骨质减少患者的FRAX评分最差,合并症(如2型糖尿病和高血压)的发生率高于年轻患者(均为p)。结论:根据最新的国际指南,骨质减少患者约占我们整个系列患者的五分之一,其中三分之二符合手术指征。在符合或不符合手术标准的骨质减少的PHPT患者之间,密度测量数据和估计的骨折风险都没有差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Estimated fracture risk in osteopenic patients with primary hyperparathyroidism.

Background: While osteoporosis in primary hyperparathyroidism (PHPT) is widely studied, PHPT patients with osteopenia remain less characterized. This study aimed to evaluate the prevalence, biochemical features, and estimated fracture risk of osteopenic PHPT patients in a real-life cohort.

Methods: We retrospectively analyzed a consecutive series of PHPT patients with available densitometric data at three sites. Postmenopausal women and men over 50 years old with PHPT and osteopenia were selected. FRAX scores were used to estimate fracture risk, and subgroup analyses were conducted based on sex, age, and PHPT clinical presentation.

Results: One hundred out of 439 PHPT patients (22.8%) were osteopenic. As compared to osteopenic women, osteopenic men were older (p = 0.03), had higher BMD at the spine and femoral neck (p = 0.007 and p = 0.006, respectively), and more frequent occurrence of nephrolithiasis (p = 0.046). Osteopenic patients older than 65 years had worst FRAX scores and higher prevalence of comorbidities, as type 2 diabetes and hypertension, than their younger counterparts (both p < 0.001). FRAX scores of osteopenic PHPT patients were not different according to their clinical classification of PHPT.

Conclusions: Patients with osteopenia account for about one fifth of our whole series and two thirds of them met surgical indication according to latest international guidelines. Neither densitometric data nor estimated fracture risk differed between osteopenic PHPT patients meeting or not surgical criteria.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Endocrine
Endocrine ENDOCRINOLOGY & METABOLISM-
CiteScore
6.50
自引率
5.40%
发文量
295
审稿时长
1.5 months
期刊介绍: Well-established as a major journal in today’s rapidly advancing experimental and clinical research areas, Endocrine publishes original articles devoted to basic (including molecular, cellular and physiological studies), translational and clinical research in all the different fields of endocrinology and metabolism. Articles will be accepted based on peer-reviews, priority, and editorial decision. Invited reviews, mini-reviews and viewpoints on relevant pathophysiological and clinical topics, as well as Editorials on articles appearing in the Journal, are published. Unsolicited Editorials will be evaluated by the editorial team. Outcomes of scientific meetings, as well as guidelines and position statements, may be submitted. The Journal also considers special feature articles in the field of endocrine genetics and epigenetics, as well as articles devoted to novel methods and techniques in endocrinology. Endocrine covers controversial, clinical endocrine issues. Meta-analyses on endocrine and metabolic topics are also accepted. Descriptions of single clinical cases and/or small patients studies are not published unless of exceptional interest. However, reports of novel imaging studies and endocrine side effects in single patients may be considered. Research letters and letters to the editor related or unrelated to recently published articles can be submitted. Endocrine covers leading topics in endocrinology such as neuroendocrinology, pituitary and hypothalamic peptides, thyroid physiological and clinical aspects, bone and mineral metabolism and osteoporosis, obesity, lipid and energy metabolism and food intake control, insulin, Type 1 and Type 2 diabetes, hormones of male and female reproduction, adrenal diseases pediatric and geriatric endocrinology, endocrine hypertension and endocrine oncology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信